Sha-Sha Wang Fang Wang Zhen Zeng Fang Gao Huan-Huan Liu Hui-Na Wang Yi Hu Hai-Feng Qin
10.3389/fonc.2022.929763
Front Oncol
2022 Sep 26;12:929763.
ret intergenic fusion lung adenocarcinoma novel intergenic pralsetinib tyrosine kinase inhibitors
CC BY
https://pubmed.ncbi.nlm.nih.gov/36226049/
Case Reports
PMC9548572
36226049
Case Report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient
2022